IRIDEX CORP IRIX
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus
Chart by TradingView
4/9
Piotroski F — financial health
-8.01
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2026 | $52.7M | -$4.4M | $19.2M | -$2.3M | $4.9M |
| 2024 | $48.7M | -$8.9M | $19.5M | -$7.3M | $2.1M |
| 2023 | $51.9M | -$9.6M | $21.8M | -$6.9M | $9.5M |
| 2022 | $57.0M | -$7.5M | $25.4M | -$9.8M | $17.2M |
| 2022 | $53.9M | -$5.2M | $22.8M | $8.0M | $23.3M |
| 2021 | $36.3M | -$6.3M | $15.6M | -$3.3M | $17.4M |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Dizon Romeo R | Chief Financial Officer | 2026-06-13 | Tax withheld | 2,691 | $1.12 |
| Mercer Patrick | President and CEO | 2026-06-13 | Tax withheld | 3,990 | $1.12 |
| Dizon Romeo R | Chief Financial Officer | 2026-06-12 | Buy | 975 | $1.14 |
| Dizon Romeo R | Chief Financial Officer | 2026-06-11 | Buy | 1,675 | $1.14 |
| Dizon Romeo R | Chief Financial Officer | 2026-06-08 | Buy | 2,400 | $1.12 |
| Dizon Romeo R | Chief Financial Officer | 2026-06-05 | Buy | 2,521 | $1.15 |
| Dizon Romeo R | Chief Financial Officer | 2026-06-03 | Buy | 2,400 | $1.17 |
| Mercer Patrick | President and CEO | 2026-05-26 | Tax withheld | 19,233 | $1.01 |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -8.01 (distress)
- Working capital / assets 0.413
- Retained earnings / assets -3.171
- EBIT / assets -0.088
- Equity / liabilities 0.203
Source: SEC EDGAR filings · CIK 0001006045 · as of 2026-01-03. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.